LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.4350
-0.0050 (-1.14%)
At close: Jan 9, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 52.73 million as of January 9, 2026. Its market cap has increased by 18.55% in one year.
Market Cap
52.73M
Enterprise Value
74.33M
Revenue
26.80M
Ranking
n/a
PE Ratio
19.17
Stock Price
0.44
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 52.73M, a decrease of -14.50%. That is a compound annual growth rate of -5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 52.73M | 24.29% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.70B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.07B |
| Trulieve Cannabis | 2.05B |
| Sienna Senior Living | 2.00B |
| Cronos Group | 1.43B |
| WELL Health Technologies | 1.07B |